The correlation between PD-L1 expression and clinicopathological features of CRC was inconsistent, and the independent impacts of PD-L1 expression on CRC prognosis were unclear in the previous meta-analyses [20–23]. This evidence concerns the gene CD274 and colorectal carcinoma.